1. Home
  2. ITCI vs DUOL Comparison

ITCI vs DUOL Comparison

Compare ITCI & DUOL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITCI
  • DUOL
  • Stock Information
  • Founded
  • ITCI 2002
  • DUOL 2011
  • Country
  • ITCI United States
  • DUOL United States
  • Employees
  • ITCI N/A
  • DUOL N/A
  • Industry
  • ITCI Biotechnology: Pharmaceutical Preparations
  • DUOL Computer Software: Prepackaged Software
  • Sector
  • ITCI Health Care
  • DUOL Technology
  • Exchange
  • ITCI Nasdaq
  • DUOL Nasdaq
  • Market Cap
  • ITCI 13.5B
  • DUOL 14.9B
  • IPO Year
  • ITCI N/A
  • DUOL 2021
  • Fundamental
  • Price
  • ITCI $126.97
  • DUOL $394.83
  • Analyst Decision
  • ITCI Buy
  • DUOL Buy
  • Analyst Count
  • ITCI 13
  • DUOL 13
  • Target Price
  • ITCI $103.62
  • DUOL $363.60
  • AVG Volume (30 Days)
  • ITCI 5.8M
  • DUOL 547.6K
  • Earning Date
  • ITCI 02-20-2025
  • DUOL 02-27-2025
  • Dividend Yield
  • ITCI N/A
  • DUOL N/A
  • EPS Growth
  • ITCI N/A
  • DUOL N/A
  • EPS
  • ITCI N/A
  • DUOL 1.83
  • Revenue
  • ITCI $613,728,000.00
  • DUOL $689,459,000.00
  • Revenue This Year
  • ITCI $48.43
  • DUOL $42.79
  • Revenue Next Year
  • ITCI $38.10
  • DUOL $29.90
  • P/E Ratio
  • ITCI N/A
  • DUOL $210.87
  • Revenue Growth
  • ITCI 46.08
  • DUOL 42.47
  • 52 Week Low
  • ITCI $62.78
  • DUOL $145.05
  • 52 Week High
  • ITCI $128.00
  • DUOL $385.00
  • Technical
  • Relative Strength Index (RSI)
  • ITCI 84.04
  • DUOL 75.46
  • Support Level
  • ITCI $126.88
  • DUOL $352.00
  • Resistance Level
  • ITCI $127.36
  • DUOL $370.77
  • Average True Range (ATR)
  • ITCI 0.44
  • DUOL 17.68
  • MACD
  • ITCI -0.90
  • DUOL 6.88
  • Stochastic Oscillator
  • ITCI 55.86
  • DUOL 92.91

About ITCI Intra-Cellular Therapies Inc.

Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.

About DUOL Duolingo Inc.

Duolingo Inc is a technology company that develops mobile learning platform to learn languages and is the top-grossing app in the Education category on both Google Play and the Apple App Store. Its products are powered by sophisticated data analytics and artificial intelligence and delivered with class art, animation, and design to make it easier for learners to stay motivated master new material, and achieve their learning goals. Its solutions include The Duolingo Language Learning App, Super Duolingo, Duolingo English Test: AI-Driven Language Assessment, Duolingo For Schools, Duolingo ABC, and Duolingo Math. It has three predominant sources of revenue; time-based subscriptions, in-app advertising placement by third parties, and the Duolingo English Test.

Share on Social Networks: